Lynx Financial
Portfolio and clients

Companies we have invested in or served.

59 innovators in pharmaceuticals, diagnostics and medical devices, across 14 countries.

  • 3-V
  • Adient
  • AFFiRiS
  • Alveo
  • Arch
  • Aridis
  • AscentX
  • Aurealis
  • Avacta
  • Avelas
  • bioAffinity
  • Biocept
  • Biotron
  • Bluesky
  • Bonti
  • Boyd
  • Calcivis
  • Cellerant
  • Centrexion
  • Compass
  • Diffusion
  • ELK
  • Elucida
  • Excera
  • Exicure
  • Faron
  • Humanigen
  • HygieaCare
  • Insurgical
  • Isarna
  • Ischemix
  • Kona
  • Lixte
  • Marginum
  • Mobidiag
  • Modra
  • Navigate
  • NeuroGeneration
  • Northshore
  • Nova
  • Novian
  • Novuson
  • OcuTerra
  • Oncolytics
  • Oncotelic
  • OpGen
  • ProMore
  • Rapid
  • Renova Therapeutics
  • Reviva
  • Rexgenero
  • Scioto
  • Solinas
  • SynDev
  • Vedantra
  • Vivaldi
  • Waveguide
  • X4 Pharmaceuticals
  • Xagenic
Where we have worked

14 countries, 4 regions.

The companies above are based across the world's major healthcare markets.

Asia-Pacific

China · Australia

North America

United States · Canada

Middle East

Israel

Europe

Finland · Sweden · Germany · France · United Kingdom · Poland · Netherlands · Switzerland · Austria